The Beauty Health Company

Alghazwi v. The Beauty Health Company et al., (Case No. 23-cv-09733), C.D. Cal.

Stock ticker:

After the market closed on November 13, 2023, The Beauty Health Company announced Q3 2023 financial results in which it disclosed that “[t]he quarter was overshadowed by lower-than-expected U.S. revenue and $63.1 million in restructuring charges related to device upgrades of early generation Syndeo devices.” The Company also revised its 2023 net sales and EBITDA margin guidance down and suspended it long-term 2025 financial outlook.

Shares of The Beauty Health Company stock dropped approximately 40% in afterhours trading on November 13, 2023, and fell more than 60% in intraday trading on November 14, 2023.

Download Complaint

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.